Aptadir raises EUR 40m seed to advance gene-reactivating RNA platform
Milan-based Aptadir Therapeutics has raised EUR 40 million (USD 45 million) in a seed financing round led by 4BIO Capital to push forward its pipeline...
This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info